Review



tigecycline evaluation surveillance trial (test)  (Pfizer Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Pfizer Inc tigecycline evaluation surveillance trial (test)
    Tigecycline Evaluation Surveillance Trial (Test), supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tigecycline+evaluation+surveillance+trial+(test)/tigecycline+evaluation+surveillance+trial++test+/pmc11269650__mmc1-32-32-18
    Average 90 stars, based on 1 article reviews
    tigecycline evaluation surveillance trial (test) - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Diagnostic Assay:

    Article Title: The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis
    Article Snippet: 42 Pfizer ATLAS Programme: the Antimicrobial Testing Leadership and Surveillance (ATLAS) database 43 includes the Tigecycline Evaluation Surveillance Trial (TEST), the Assessing Worldwide Antimicrobial 44 Resistance Evaluation (AWARE) and the International Network for Optimal Resistance Monitoring 45 (INFORM) programs.

    Article Title:
    Article Snippet: Sites are in the 209 USA, Europe, Latin America, parts of Asia, and the Western Pacific 210 • Pfizer ATLAS Programme: the Antimicrobial Testing Leadership and Surveillance (ATLAS) database 211 includes the Tigecycline Evaluation Surveillance Trial (TEST), the Assessing Worldwide Antimicrobial 212 Resistance Evaluation (AWARE) and the International Network for Optimal Resistance Monitoring 213 (INFORM) programs.

    Article Title: Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019
    Article Snippet: 248 • Pfizer ATLAS Programme: the Antimicrobial Testing Leadership and Surveillance (ATLAS) 249 database includes the Tigecycline Evaluation Surveillance Trial (TEST), the Assessing 250 Worldwide Antimicrobial Resistance Evaluation (AWARE) and the International Network for 251 Optimal Resistance Monitoring (INFORM) programs.

    Article Title: The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis
    Article Snippet: Diagnostic antimicrobial susceptibility testing: 39 information on hospital admission and discharge, pathogens cultured, resistance susceptibility test and 40 antibiotics prescribed between 2005 and 2015 from the MCR Unit The Gambia, now part of the London 41 • Pfizer ATLAS Programme: the Antimicrobial Testing Leadership and Surveillance (ATLAS) database 42 includes the Tigecycline Evaluation Surveillance Trial (TEST), the Assessing Worldwide Antimicrobial 43 Resistance Evaluation (AWARE) and the International Network for Optimal Resistance Monitoring 44 (INFORM) programs.

    Article Title: Seeking patterns of antibiotic resistance in ATLAS, an open, raw MIC database with patient metadata
    Article Snippet: The Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, led by Pfizer, is the union of 3 previous surveillance programs: the Tigecycline Evaluation Surveillance Trial (TEST) program, instigated by Pfizer in 2004, the International Network for Optimal Resistance Monitoring (INFORM) program, e↵ected by AstraZeneca from 2012 to 2017, and the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) program, also run by AstraZeneca from 2008 until 2017.

    Cell Culture:

    Article Title: The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis
    Article Snippet: 42 Pfizer ATLAS Programme: the Antimicrobial Testing Leadership and Surveillance (ATLAS) database 43 includes the Tigecycline Evaluation Surveillance Trial (TEST), the Assessing Worldwide Antimicrobial 44 Resistance Evaluation (AWARE) and the International Network for Optimal Resistance Monitoring 45 (INFORM) programs.

    Article Title:
    Article Snippet: Sites are in the 209 USA, Europe, Latin America, parts of Asia, and the Western Pacific 210 • Pfizer ATLAS Programme: the Antimicrobial Testing Leadership and Surveillance (ATLAS) database 211 includes the Tigecycline Evaluation Surveillance Trial (TEST), the Assessing Worldwide Antimicrobial 212 Resistance Evaluation (AWARE) and the International Network for Optimal Resistance Monitoring 213 (INFORM) programs.

    Article Title: Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019
    Article Snippet: 248 • Pfizer ATLAS Programme: the Antimicrobial Testing Leadership and Surveillance (ATLAS) 249 database includes the Tigecycline Evaluation Surveillance Trial (TEST), the Assessing 250 Worldwide Antimicrobial Resistance Evaluation (AWARE) and the International Network for 251 Optimal Resistance Monitoring (INFORM) programs.

    Article Title: The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis
    Article Snippet: Diagnostic antimicrobial susceptibility testing: 39 information on hospital admission and discharge, pathogens cultured, resistance susceptibility test and 40 antibiotics prescribed between 2005 and 2015 from the MCR Unit The Gambia, now part of the London 41 • Pfizer ATLAS Programme: the Antimicrobial Testing Leadership and Surveillance (ATLAS) database 42 includes the Tigecycline Evaluation Surveillance Trial (TEST), the Assessing Worldwide Antimicrobial 43 Resistance Evaluation (AWARE) and the International Network for Optimal Resistance Monitoring 44 (INFORM) programs.

    Article Title: Seeking patterns of antibiotic resistance in ATLAS, an open, raw MIC database with patient metadata
    Article Snippet: The Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, led by Pfizer, is the union of 3 previous surveillance programs: the Tigecycline Evaluation Surveillance Trial (TEST) program, instigated by Pfizer in 2004, the International Network for Optimal Resistance Monitoring (INFORM) program, e↵ected by AstraZeneca from 2012 to 2017, and the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) program, also run by AstraZeneca from 2008 until 2017.



    Similar Products

    90
    Pfizer Inc tigecycline evaluation surveillance trial (test)
    Tigecycline Evaluation Surveillance Trial (Test), supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tigecycline+evaluation+surveillance+trial+(test)/tigecycline+evaluation+surveillance+trial++test+/pmc11269650__mmc1-32-32-18
    Average 90 stars, based on 1 article reviews
    tigecycline evaluation surveillance trial (test) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Pfizer Inc tigecycline evaluation surveillance trial (test) program
    Tigecycline Evaluation Surveillance Trial (Test) Program, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tigecycline+evaluation+surveillance+trial+(test)/tigecycline+evaluation+surveillance+trial++test+/pmc09133080__41467_2022_30635_MOESM1_ESM-12-20-28
    Average 90 stars, based on 1 article reviews
    tigecycline evaluation surveillance trial (test) program - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results